Selected 2004 Venture Capital Transactions as Company Counsel

Selected 2004 Venture Capital Transactions as Company Counsel

Publication

In 2004, we served as company counsel in more than 150 venture financings raising more than $1.5 billion, including some of the largest and most prominent deals of the year. In the past five years, we have served as company counsel in more than 750 venture financings raising more than $10 billion. We are counsel to more venture capital-backed companies in the eastern half of the United States than any other law firm in the country. Selected venture financings from 2004 are listed below:

  • A123 Systems — $20.0 million
  • Acopia Networks— $25.0 million
  • Aegis Semiconductor— $10.0 million
  • Airwide Solutions— $10.0 million
  • Archivas— $10.0 million
  • Authoria— $10.5 million
  • Compound Therapeutics — $15.5 million
  • Context Media— $11.0 million
  • CoreStreet — $8.5 million
  • Endeca Technologies— $15.0 million
  • Evident Software— $10.0 million
  • Gloucester Pharmaceuticals— $29.0 million
  • Icera— $22.5 million
  • Idenix Pharmaceuticals— $75.6 million
  • IMlogic — $16.0 million
  • Infinity Pharmaceuticals — $25 million
  • Invento Networks— $10.0 million
  • Kalido Holdings— $10.0 million
  • Microbia— $40.0 million
  • Mobile Cohesion— $6.0 million
  • Momenta Pharmaceuticals— $20.5 million
  • Neotropix— $10.0 million
  • Netezza — $15 million
  • NxStage — $20 million
  • Ounce Labs— $10.0 million
  • PharMetrics — $8.0 million
  • Polychromix — $8.0 million
  • Propagate Networks— $8.0 million
  • SiCortex— $21.0 million
  • Softricity — $7.5 million
  • Starent Networks— $25.0 million
  • SurfKitchen— $17.5 million
  • Transitive — $11.5 million
  • Veveo.tv — $14 million
  • Virtual Iron — $12 million
  • VistaPrint Limited— $52.0 million

Notice

We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.